Research Studies

PNRR Study on Vitamin B6

Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels …

PNRR Study on Vitamin B6 Read More »

Research Study Back on Track!

Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to …

Research Study Back on Track! Read More »

Translational Pain Research Study

Do you have numbness and tingling or pain in your feet from diabetes? Do you have pain after shingles (postherpetic pain)? The Translational Pain Research Group at the Brigham and Women’s Hospital in Boston, Massachusetts, is seeking volunteers who have diabetic nerve pain or pain following shingles to participate in a research study. Volunteers who …

Translational Pain Research Study Read More »

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain

Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be found at ClinicalTrials.gov here. PURPOSE OF THE STUDY In this study, the Sponsor, Erchonia Corporation, and investigators are studying the use of a device called the Erchonia® FX-635™ that gives …

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain Read More »

Key Data from FPN Patient Registry Highlighted in Top Medical Journal

In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from the Peripheral Neuropathy Research Registry (PNRR). This is the first ever overall study performed on this Patient Registry and one that truly highlights the importance of this dataset for current …

Key Data from FPN Patient Registry Highlighted in Top Medical Journal Read More »

Gene Therapy Blocks Peripheral Nerve Damage in Mice

In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the …

Gene Therapy Blocks Peripheral Nerve Damage in Mice Read More »

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN …

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S. Read More »

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy

NeuroNEXT and the National Institute of Neurological Disorders and Stroke (NINDS) are undergoing a double-blind, placebo clinical trial looking at the effectiveness of treating peripheral neuropathy with the FDA-approved drug, topiramate. This is a 96-week placebo-controlled trial of topiramate at a target dose of 100 mg daily (50 mg twice daily) as a potentially disease …

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy Read More »

diabetic peripheral neuropathy treatment

Research Study for Painful Diabetic Peripheral Neuropathy

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy. Aptinyx Inc. is conducting a research study evaluating multiple doses of its investigational drug NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy. Enrollment into this …

Research Study for Painful Diabetic Peripheral Neuropathy Read More »

Long-Time Course of Idiopathic Small Fiber Neuropathy

Small study offers hope to patients with small fiber neuropathy Many patients diagnosed with small fiber neuropathy, one of the many forms of peripheral neuropathy, ask their physicians about their prognosis. Physicians are usually not sure how to answer, since there is not a lot of research to back whether the condition will improve or …

Long-Time Course of Idiopathic Small Fiber Neuropathy Read More »

Send this to a friend